Burning Rock Biotech (BNR) Competitors $3.38 +0.15 (+4.49%) As of 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BNR vs. XGN, CORBF, EUDA, NAKA, KDLY, QIPT, ATPC, SERA, OPGN, and PIIIShould you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include Exagen (XGN), Global Cord Blood (CORBF), EUDA Health (EUDA), KindlyMD (NAKA), Kindly MD (KDLY), Quipt Home Medical (QIPT), Agape ATP (ATPC), Sera Prognostics (SERA), OpGen (OPGN), and P3 Health Partners (PIII). These companies are all part of the "healthcare" industry. Burning Rock Biotech vs. Its Competitors Exagen Global Cord Blood EUDA Health KindlyMD Kindly MD Quipt Home Medical Agape ATP Sera Prognostics OpGen P3 Health Partners Burning Rock Biotech (NASDAQ:BNR) and Exagen (NASDAQ:XGN) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk. Does the media refer more to BNR or XGN? In the previous week, Exagen had 1 more articles in the media than Burning Rock Biotech. MarketBeat recorded 1 mentions for Exagen and 0 mentions for Burning Rock Biotech. Burning Rock Biotech's average media sentiment score of 0.00 equaled Exagen'saverage media sentiment score. Company Overall Sentiment Burning Rock Biotech Neutral Exagen Neutral Do institutionals and insiders hold more shares of BNR or XGN? 30.0% of Burning Rock Biotech shares are held by institutional investors. Comparatively, 75.3% of Exagen shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by insiders. Comparatively, 12.6% of Exagen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better valuation and earnings, BNR or XGN? Exagen has lower revenue, but higher earnings than Burning Rock Biotech. Exagen is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBurning Rock Biotech$523.28M0.07-$47.49M-$1.89-1.79Exagen$55.64M2.58-$15.11M-$0.84-8.02 Do analysts rate BNR or XGN? Exagen has a consensus target price of $7.50, suggesting a potential upside of 11.34%. Given Exagen's stronger consensus rating and higher probable upside, analysts clearly believe Exagen is more favorable than Burning Rock Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Exagen 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, BNR or XGN? Burning Rock Biotech has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500. Comparatively, Exagen has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500. Is BNR or XGN more profitable? Exagen has a net margin of -27.34% compared to Burning Rock Biotech's net margin of -45.41%. Burning Rock Biotech's return on equity of -38.33% beat Exagen's return on equity.Company Net Margins Return on Equity Return on Assets Burning Rock Biotech-45.41% -38.33% -25.34% Exagen -27.34%-133.69%-34.87% SummaryExagen beats Burning Rock Biotech on 10 of the 15 factors compared between the two stocks. Get Burning Rock Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BNR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNR vs. The Competition Export to ExcelMetricBurning Rock BiotechTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$36.32M$2.40B$13.04B$9.01BDividend YieldN/A1.34%2.58%4.11%P/E Ratio-1.7931.4228.5920.07Price / Sales0.0736.5339.59109.13Price / CashN/A39.2125.1456.90Price / Book0.465.826.255.70Net Income-$47.49M$32.32M$187.50M$248.47M7 Day Performance-1.03%4.77%2.84%2.92%1 Month Performance13.26%8.28%4.82%5.77%1 Year Performance-44.76%51.43%34.94%21.39% Burning Rock Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNRBurning Rock Biotech1.0119 of 5 stars$3.38+4.5%N/A-47.8%$36.32M$523.28M-1.791,390XGNExagen2.8081 of 5 stars$6.97-3.6%$7.50+7.6%+291.6%$154M$55.64M-8.30220CORBFGlobal Cord BloodN/A$1.18-6.3%N/A+45.0%$143.43M$196.12M0.001,200Gap DownEUDAEUDA Health0.7706 of 5 stars$3.58-3.8%N/A-5.6%$138.21M$4.01M0.002Gap UpNAKAKindlyMDN/A$16.30+14.6%N/AN/A$85.74M$2.72M0.00N/APositive NewsKDLYKindly MDN/A$14.22+2.0%N/A+518.6%$85.63M$2.47M-18.47N/APositive NewsQIPTQuipt Home Medical2.3772 of 5 stars$1.93+1.0%$2.85+47.7%-42.9%$82.98M$245.91M-9.191,200ATPCAgape ATP0.064 of 5 stars$1.37-12.7%N/A-65.5%$78.51M$1.32M-2.2840Positive NewsGap DownSERASera Prognostics1.4474 of 5 stars$1.87-2.6%N/A-56.2%$72.33M$80K-1.99120Positive NewsGap DownOPGNOpGenN/A$4.88flatN/A+80.5%$49.13M$2.67M0.00100Upcoming EarningsGap DownPIIIP3 Health Partners2.9111 of 5 stars$6.17-1.3%$16.25+163.4%-72.4%$44.92M$1.50B-0.13500News CoverageGap Down Related Companies and Tools Related Companies Exagen Competitors Global Cord Blood Competitors EUDA Health Competitors KindlyMD Competitors Kindly MD Competitors Quipt Home Medical Competitors Agape ATP Competitors Sera Prognostics Competitors OpGen Competitors P3 Health Partners Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BNR) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Burning Rock Biotech Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Burning Rock Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.